OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Neurology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)

Article	Citations
The role of innate immune genes in Alzheimer's disease	110
Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management	98
Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease	63
MRI findings as markers of idiopathic intracranial hypertension	56
Motion sickness: current concepts and management	49
The state of telemedicine for persons with Parkinson's disease	48
What is ‘Alzheimer's disease’? The neuropathological heterogeneity of clinically defined Alzheimer's dementia	48
Acute bacterial meningitis	45
Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegeneration	42
Update on neuroimaging in disorders of consciousness	42
Update on genetics of amyotrophic lateral sclerosis	37
Advances in the treatment of neuropathic pain	36
Neuralgic amyotrophy	32
Dravet syndrome	32
Lesion network mapping for symptom localization: recent developments and future directions	31
Fragile X-associated tremor/ataxia syndrome: pathophysiology and management	31
MRI in disorders of consciousness	29
Overview of tau PET molecular imaging	26
Vaccinations in multiple sclerosis patients receiving disease-modifying drugs	26
Functional MRI in migraine	25
Vestibular and auditory manifestations of migraine	25
Neuromuscular complications of coronavirus disease-19	22
Autoimmune nodopathies, an emerging diagnostic category	22
Deep brain stimulation in dystonia: factors contributing to variability in outcome in short and long term follow-up	22
Stroke epidemiology and COVID-19 pandemic	21

Interictal autonomic dysfunction	21
New drugs for multiple sclerosis: new treatment algorithms	21
Central nervous system tuberculosis	21
Rehabilitation of cortically induced visual field loss	20
Microglia in multiple sclerosis – pathogenesis and imaging	20
Use of disease-modifying drugs during pregnancy and breastfeeding	19
Learning from the comorbidities of epilepsy	19
Reproducibility and replicability in neuroimaging data analysis	19
Intravenous thrombolysis for acute ischemic stroke: why not?	19
Optic neuropathy and diplopia from thyroid eye disease: update on pathophysiology and treatment	18
Ménière's disease: new guidelines, subtypes, imaging, and more	18
Stopping disease-modifying therapy in relapsing and progressive multiple sclerosis	18
Management of autoimmune encephalitis	18
Advances in the genetic classification of amyotrophic lateral sclerosis	17
What have we learned from cognition in the oldest-old	17
Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis	17
The recent surge of functional movement disorders: social distress or greater awareness?	17
Recent advances in pharmacotherapy for epilepsy	17
Long COVID and especially headache syndromes	17
Ataxin-2 gene: a powerful modulator of neurological disorders	16
Chemotherapy and targeted therapies for meningiomas: what is the evidence?	16
Central vein sign and iron rim in multiple sclerosis: ready for clinical use?	16
Current concepts in acute vestibular syndrome and video-oculography	16
Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and genetic aspects, and management	16
Insular seizures and epilepsies: Ictal semiology and minimal invasive surgery	16
Mechanisms of coronavirus infectious disease 2019-related neurologic diseases	16
Updates on ophthalmic imaging features of optic disc drusen, papilledema, and optic disc edema	15
Neuropathogenesis of acute coronavirus disease 2019	15
Peripheral white blood cell responses as emerging biomarkers for patient stratification and prognosis in acute spinal cord injury	15
Traumatic peripheral nerve injuries: diagnosis and management	15
Multiple sclerosis in the era of COVID-19: disease course, DMTs and SARS-CoV2 vaccinations	15
Methods of visual assessment in children with cortical visual impairment	15
Parkinson's disease – genetic cause	14
Targets for migraine treatment: beyond calcitonin gene-related peptide	14
The current landscape of epilepsy genetics: where are we, and where are we going?	14
Biomarkers for amyotrophic lateral sclerosis	14
Immunotherapy in autoimmune encephalitis	14
Unveiling the neuroimaging-genetic intersections in the human brain	14
Update on neuroimaging in brain tumours	14
A reappraisal of injuries and accidents in people with epilepsy	13
Attention deficit/hyperactivity disorder and epilepsy	13
Novel pathophysiological insights in autoimmune myasthenia gravis	13
Oculopharyngodistal myopathy	13
New and emerging pharmacologic treatments for developmental and epileptic encephalopathies	13
Therapeutic strategies for C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia	13
Influence of sex hormones on vestibular disorders	13
Antibody testing in neuropathy associated with anti-Myelin-Associated Glycoprotein antibodies: where we are after 40 years	13
Expanding the clinical spectrum of idiopathic intracranial hypertension	12
Vestibular-autonomic interactions: beyond orthostatic dizziness	12
Equitable partnerships between scientists and persons living with spinal cord injury will strengthen research scope, quality, and outcomes	12

Triggers of migraine: where do we stand?	12
Dysregulation of energy homeostasis in amyotrophic lateral sclerosis	12
Telemedicine for neuro-ophthalmology: challenges and opportunities	12
Update on the management of status epilepticus	12
Neuropathology and neuroanatomy of TDP-43 amyotrophic lateral sclerosis	12
Vestibular function testing in the 21st century: video head impulse test, vestibular evoked myogenic potential, video nystagmography; which tests will provide answers?	12
Brief exposure to systemic hypoxia enhances plasticity of the central nervous system in spinal cord injured animals and man	12
Data-driven approaches to neuroimaging biomarkers for neurological and psychiatric disorders: emerging approaches and examples	12
Bilateral vestibulopathy: the causes, diagnosis, and treatments	12
Sudden unexpected death in epilepsy	12
Advanced neuroimaging techniques in epilepsy	11
Novel approaches to prediction in severe brain injury	11
Connecting tremors – a circuits perspective	11
Fluid phase biomarkers in multiple sclerosis	11
Serotonergic therapy in epilepsy	11
The challenge of amyotrophic lateral sclerosis descriptive epidemiology: to estimate low incidence rates across complex phenotypes in different geographic areas	11
Highly effective disease-modifying treatment as initial MS therapy	11
Autoimmune movement disorders with neuronal antibodies – an update	11
Update on dermatomyositis	11
The role of telemedicine in acute stroke treatment in times of pandemic	11
Predicting disability worsening in relapsing and progressive multiple sclerosis	10
Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection	10
Deciphering the contributions of neuroinflammation to neurodegeneration: lessons from antibody-mediated encephalitis and coronavirus disease 2019	10
Immunotherapy approaches for adult glioma: knowledge gained from recent clinical trials	10
Visual field defects in temporal lobe epilepsy surgery	10
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers	10
New insights into the Immune TME of adult-type diffuse gliomas	10
Cancer stem cells in gliomas: evolving concepts and therapeutic implications	10
Progress in spinal muscular atrophy research	9
Update in the clinical application of focused ultrasound	9
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection	9
Update on alpha-synuclein-based biomarker approaches in the skin, submandibular gland, gastrointestinal tract, and biofluids	9
Advances in the management of acute ischemic stroke	9
The 2021 WHO classification of central nervous system tumors: what neurologists need to know	9
Assessment and treatment of neurogenic dysphagia in stroke and Parkinson's disease	9
Network dysfunction in pre and postsurgical epilepsy: connectomics as a tool and not a destination	9